Shohei Yoshida
About
In The Last Decade
Shohei Yoshida
66 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 392
- Geriatrics and Gerontology 320
- Physiology 216
- Physiology 163
- Oncology 159
Countries citing papers authored by Shohei Yoshida
This map shows the geographic impact of Shohei Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shohei Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shohei Yoshida more than expected).
Fields of papers citing papers by Shohei Yoshida
This network shows the impact of papers produced by Shohei Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shohei Yoshida. The network helps show where Shohei Yoshida may publish in the future.
Co-authorship network of co-authors of Shohei Yoshida
This figure shows the co-authorship network connecting the top 25 collaborators of Shohei Yoshida. A scholar is included among the top collaborators of Shohei Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shohei Yoshida. Shohei Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 8 | |
| 10 | 40 | |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 9 | |
| 15 | Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice breakdown → | 628 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | CD34+CD31+ immature myeloid cells (IMC) as an inhibitor cell on the production of antimicrobial peptide: III. Translational studies of glycyrrhizin in humanized NOD-SCID IL-2r{gamma}-/- mice (NOD-SCID mice) | 1 |
| 19 | 14 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.